Human papillomavirus (HPV) is a ubiquitous human pathogen that causes cervical and
other anogenital cancers as well as genital warts and recurrent respiratory papillomatosis …

BACKGROUND: The human papillomaviruses (HPV) are simple, nonenveloped, double-
stranded DNA viruses, which are responsible for an enormous global burden of genital …

Background The placebo arm of human papillomavirus (HPV) vaccine trials helps define the
natural history of genital warts (GW) Methods Women enrolled in the placebo arm (n= 8800) …

OBJECTIVES. Prophylactic vaccines against human papillomavirus (HPV) are expected to
be available for public use by 2007 and likely will be targeted to preadolescent children …

Objective and Participants: In 2006, the authors examined intention to receive an HPV
vaccine among 340 college students. Methods: A total of 138 men and 202 women …

Our aim was to determine country-specific attitudes and perceptions of patients with genital
warts and to understand the psychosexual impact of the disease and its treatment. We used …

Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV
types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV …

Names: King, Bruce M., author.| Regan, Pamela C., author. Title: Human sexuality
today/Bruce M. King, Pamela C. Regan. Description: 9th edition.| Hoboken, NJ …

Background Human papillomavirus (HPV) is a common sexually transmitted infection (STI)
known to cause cervical cancer and genital warts. However, making the genital warts aspect …

In theory, recognition that a pandemic infection is responsible for more than half a million
cancer cases each year would attract huge media attention, and infection control would …